Laurent Louis Jean Goux - 01 Mar 2026 Form 3 Insider Report for Krystal Biotech, Inc. (KRYS)

Reporting relationship: EVP, Head of International
Issuer ticker: KRYS
Reported as of: 01 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 06 Mar 2026, 18:26:21 UTC
Source filing: View source filing
Reporting owner signature: /s/ Laurent Goux

Key filing fact

Laurent Louis Jean Goux filed Form 3 for Krystal Biotech, Inc. (KRYS) on 06 Mar 2026.

Key facts

This page summarizes Laurent Louis Jean Goux's Form 3 filing for Krystal Biotech, Inc. (KRYS).
0 reported transactions and 9 derivative rows are listed below.
Accepted by SEC: 06 Mar 2026, 18:26.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002114613 Primary reporting owner

Goux Laurent Louis Jean

Relationship: EVP, Head of International
Address: C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH
Signature: /s/ Laurent Goux
Signature date: 06 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KRYS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 919
Date: 01 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRYS holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,050
Exercise price: $275.64
Footnotes: F1

KRYS holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,628
Exercise price
Footnotes: F2, F3, F4

KRYS holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,449
Exercise price: $179.25
Footnotes: F5

KRYS holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 891
Exercise price
Footnotes: F3, F4, F6

KRYS holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,367
Exercise price: $159.47
Footnotes: F7

KRYS holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 674
Exercise price
Footnotes: F3, F4, F8

KRYS holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,750
Exercise price: $81.91
Footnotes: F9

KRYS holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,750
Exercise price: $63.55
Footnotes: F10

KRYS holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,000
Exercise price: $52.21
Footnotes: F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

The stock option was granted on February 27, 2026, and vests in four equal annual installments on each of the first, second, third, and fourth anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F2

The restricted stock units ("RSUs") vest in four equal annual installments with the first installment vesting on February 27, 2027.

Footnote F3

The number of RSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming the Reporting Person's continued service to the Company on all applicable vesting dates.

Footnote F4

Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date.

Footnote F5

The stock option was granted on February 28, 2025, and vested or will vest in four equal annual installments on each of the first, second, third, and fourth anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F6

The RSUs vested or will vest in four equal annual installments on each of the first, second, third, and fourth anniversaries of the grant date, February 28, 2025, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F7

The stock option was granted on February 29, 2024, and vested or will vest in four equal annual installments on each of the first, second, third, and fourth anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F8

The RSUs vested or will vest in four equal annual installments on each of the first, second, third, and fourth anniversaries of the grant date, February 29, 2024, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F9

The stock option was granted on February 28, 2023, and vested or will vest in four equal annual installments on each of the first, second, third, and fourth anniversaries of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

Footnote F10

The stock option is fully vested.

SEC remarks

Exhibit 24.1 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .